Department of Pathology, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Xicheng District, Beijing, 100053, China.
Clinical Research Center for Epilepsy, Capital Medical University, Beijing, 100053, China.
Acta Neuropathol Commun. 2023 Aug 9;11(1):129. doi: 10.1186/s40478-023-01618-6.
Focal Cortical Dysplasia (FCD) is a frequent cause of drug-resistant focal epilepsy in children and young adults. The international FCD classifications of 2011 and 2022 have identified several clinico-pathological subtypes, either occurring isolated, i.e., FCD ILAE Type 1 or 2, or in association with a principal cortical lesion, i.e., FCD Type 3. Here, we addressed the DNA methylation signature of a previously described new subtype of FCD 3D occurring in the occipital lobe of very young children and microscopically defined by neuronal cell loss in cortical layer 4. We studied the DNA methylation profile using 850 K BeadChip arrays in a retrospective cohort of 104 patients with FCD 1 A, 2 A, 2B, 3D, TLE without FCD, and 16 postmortem specimens without neurological disorders as controls, operated in China or Germany. DNA was extracted from formalin-fixed paraffin-embedded tissue blocks with microscopically confirmed lesions, and DNA methylation profiles were bioinformatically analyzed with a recently developed deep learning algorithm. Our results revealed a distinct position of FCD 3D in the DNA methylation map of common FCD subtypes, also different from non-FCD epilepsy surgery controls or non-epileptic postmortem controls. Within the FCD 3D cohort, the DNA methylation signature separated three histopathology subtypes, i.e., glial scarring around porencephalic cysts, loss of layer 4, and Rasmussen encephalitis. Differential methylation in FCD 3D with loss of layer 4 mapped explicitly to biological pathways related to neurodegeneration, biogenesis of the extracellular matrix (ECM) components, axon guidance, and regulation of the actin cytoskeleton. Our data suggest that DNA methylation signatures in cortical malformations are not only of diagnostic value but also phenotypically relevant, providing the molecular underpinnings of structural and histopathological features associated with epilepsy. Further studies will be necessary to confirm these results and clarify their functional relevance and epileptogenic potential in these difficult-to-treat children.
局灶性皮质发育不良(Focal Cortical Dysplasia,FCD)是儿童和青年药物难治性局灶性癫痫的常见原因。2011 年和 2022 年的国际 FCD 分类已经确定了几种临床病理亚型,要么是孤立的,即 FCD ILAE 1 型或 2 型,要么与主要皮质病变相关,即 FCD 3 型。在这里,我们研究了之前描述的一种新的 FCD 3D 亚型的 DNA 甲基化特征,该亚型发生在非常年幼的儿童的枕叶,在显微镜下通过皮质 4 层的神经元细胞丢失来定义。我们使用 850K BeadChip 芯片在一个回顾性队列中研究了 104 名 FCD 1A、2A、2B、3D、无 FCD 的 TLE 和 16 名无神经障碍的尸检标本的 DNA 甲基化谱,这些患者在中国或德国接受了手术。从福尔马林固定石蜡包埋组织块中提取 DNA,该组织块具有显微镜确认的病变,然后使用最近开发的深度学习算法对 DNA 甲基化谱进行生物信息学分析。我们的结果显示,FCD 3D 在常见 FCD 亚型的 DNA 甲基化图谱中处于独特的位置,也与非 FCD 癫痫手术对照或非癫痫尸检对照不同。在 FCD 3D 队列中,DNA 甲基化特征将三个组织病理学亚型分开,即脑穿通畸形周围的神经胶质瘢痕、4 层缺失和拉塞尔氏脑炎。FCD 3D 中与 4 层缺失相关的差异甲基化明确映射到与神经退行性变、细胞外基质(ECM)成分的生物发生、轴突导向和肌动蛋白细胞骨架调节相关的生物学途径。我们的数据表明,皮质畸形中的 DNA 甲基化特征不仅具有诊断价值,而且与表型相关,为与癫痫相关的结构和组织病理学特征提供了分子基础。需要进一步的研究来证实这些结果,并阐明它们在这些难以治疗的儿童中的功能相关性和致痫潜能。